Business Context and Reporting Period
Company: Local Bounti Corporation (LOCL)
Filing Type: Form 8-K (Current Report)
Date of Report: March 13, 2026
Event: Entry into a Material Definitive Agreement involving a convertible note and warrant purchase, and an amendment to an existing senior credit agreement.
Key Financial Metrics and Transaction Details
- Convertible Note Principal: $15.0 million
- Note Interest Rate: 7.0% per annum (accrued as PIK interest initially)
- Warrant Details: Right to purchase 5,500,000 shares at an exercise price of $0.125 per share; 10-year term.
- Conversion Price: $2.50 per share (subject to adjustments).
- Potential Dilution (Note Only): Up to 6,000,000 shares if fully converted at initial price.
- Use of Proceeds: Working capital, general corporate purposes, and capital expenditures.
- Senior Credit Agreement Amendments:
- Minimum liquidity covenant revised to $3.5 million through September 30, 2026, and $2.0 million thereafter.
- Minimum EBITDA covenant testing deferred to March 31, 2027.
Material Changes and Structural Terms
The filing discloses a significant capital raise via a private placement exempt from registration under Section 4(a)(2) and Rule 506 of Regulation D. Key structural changes include:
- Interest Payment Structure: Interest is payable in-kind (PIK) semi-annually starting December 31, 2026, increasing the principal balance. Cash interest payments may commence quarterly after the third anniversary (starting December 31, 2029) if conditions are met.
- Automatic Conversion: 50% of the note obligations automatically convert to equity on the fourth anniversary; the remaining 50% converts at maturity. Cash repayment is an option for the 50% tranches if specific conditions are met.
- Issuance Limitation: Issuance of shares upon conversion or warrant exercise is capped at 1% of outstanding common stock until stockholder approval is obtained (required by June 30, 2026).
- Subordination: The new Note is subordinated to the Senior Credit Agreement with Cargill Financial.
Outlook, Risks, and Contingencies
- Stockholder Approval Requirement: The Company must seek stockholder approval for the issuance of shares exceeding the 1% limit no later than June 30, 2026. Failure to obtain this approval may restrict the full conversion of the note or exercise of warrants.
- Liquidity Covenant Compliance: The company must maintain minimum liquidity levels of $3.5 million through late 2026 and $2.0 million thereafter to remain in compliance with the amended Senior Credit Agreement.
- EBITDA Deferral: The deferral of the EBITDA covenant test to 2027 suggests management is managing near-term earnings volatility or cash flow constraints.
- Unregistered Securities: The Note, Warrant, and underlying shares are unregistered and cannot be resold absent registration or an exemption.
Investor Verification Checklist
- Verify the current number of outstanding shares to assess the immediate 1% issuance cap impact.
- Confirm the Company's current cash and cash equivalents to ensure compliance with the new $3.5 million liquidity covenant.
- Monitor the schedule for the special or annual stockholder meeting required by June 30, 2026, to approve the equity issuance.
- Review the full text of the Convertible Note (Exhibit 4.1) for specific conditions required to trigger cash interest payments or cash repayment options.
- Assess the dilution impact of the 5,500,000 warrant shares at the $0.125 exercise price relative to the current market price.